Multiply Labs collaborated with these life science industry leaders to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion. The results of the proof-of-concept ...

Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Multiply Labs, a robotics firm, and Retro Biosciences, which is developing therapies to address age-related diseases, signed an agreement valued at up to $85 million to automate Retro’s approach to ...

Teradyne, Inc. (NASDAQ:TER) is one of the 10 Best Semiconductor Stocks to Buy Right Now. On August 21, it was announced that Multiply Labs developed a new robotic biomanufacturing cluster, which ...

SAN FRANCISCO--(BUSINESS WIRE)--The robotic cell therapy manufacturing Consortium founded by Multiply Labs, with initial participation from UCSF and Cytiva, announced today that Thermo Fisher ...

Combining LCGM’s world-leading process development expertise with Multiply Labs’ unique robotic technology will enable cell therapy organizations to automate proven processes without substantially ...

Multiply Labs, a San Francisco-based robotics company developing advanced automated manufacturing systems for cell therapies, announced an expansion of its collaboration with Thermo Fisher Scientific.

Financing led by Casdin Capital, with participation from Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle to support the deployment of cloud-controlled robotic systems to ...

Multiply Labs chose Universal Robots for their robotics cluster after closely evaluating several different collaborative robots, says Head of Robotics at Multiply Labs, Nadia Kreciglowa: “UR was ...